Announcements Trials
Browse Landscape

Phase

Phase 1 3

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 5Gastrointestinal 4Other solid neoplasm 3Dermatologic 3Genitourinary 2CNS 2Breast 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1

Conditions

Solid Tumors 1Solid Tumor 1Advanced Solid Tumors 1

Interventions

Cisplatin 145pembrolizumab 129Carboplatin 125Injections 108Pemetrexed 97Paclitaxel 97Gemcitabine 85Irinotecan 75Nivolumab 71Cyclophosphamide 71Docetaxel 68Bevacizumab 57Oxaliplatin 49Fluorouracil 48atezolizumab 46Capecitabine 46Etoposide 42Leucovorin 41tislelizumab 40toripalimab 36fludarabine 32Ipilimumab 30Drug Therapy 30Topotecan 29durvalumab 28Vincristine 27Early Intervention, Educational 27Radiotherapy 26Interviews as Topic 26Specimen Handling 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × pexidartinib × Other solid neoplasm × Clear all
NCT02734433 2022-04-25

Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors

Daiichi Sankyo

Phase 1 Completed
12 enrolled 22 charts
Other solid neoplasm

Advanced Solid Tumors

NCT01004861 2022-01-04

Safety Study of PLX108-01 in Patients With Solid Tumors

Daiichi Sankyo

Phase 1 Completed
132 enrolled 28 charts
Other solid neoplasm

Solid Tumor

NCT01525602 2020-07-16

Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors

Daiichi Sankyo

Phase 1 Completed
74 enrolled 22 charts
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡